Infectious Disease
Varicella
0
Pipeline Programs↗
5
Active Trials↗
3
Companies Involved↗
Varicella is an early-stage landscape with 0 programs across 3 companies. The most active players are GSK, Merck & Co., Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed6 · 38%
Withdrawn3 · 19%
Not yet recruiting2 · 13%
Unknown status2 · 13%
Enrolling by invitation2 · 13%
Recruiting1 · 6%
Clinical Trials
Trial Activity
16 trials
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
Enrolling by invitation·SSinovac (Dalian) Vaccine Technology Co., Ltd.·Phase 4·NCT05095701·703 enrolled
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine
Enrolling by invitation·SSinovac (Dalian) Vaccine Technology Co., Ltd.·Phase 4·NCT06484686·414 enrolled
Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine
Completed·ZZhejiang Provincial Center for Disease Control and Prevention·N/A·NCT02983656·394 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)